FDA finalizes guidance on adaptive trial designs
The FDA last week finalized guidance on adaptive clinical trial designs for drugs and biologics.
The 33-page guidance, which finalizes a draft version …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
